Results by: the next day, 2 days or Express test (results by 5am the next day)
It is your responsibility to make sure that your destination accepts this test. Check here
Results within 15-20 minutes
It is your responsibility to make sure that your destination accepts this test. Check here
Results by: the next day, within 2 days or Express test (results by 5am the next day)
It is your responsibility to make sure that your destination accepts this test. Check here
Results within 15-20 minutes
It is your responsibility to make sure that your destination accepts this test. Check here
Results the next day.
When returning to the UK you must take the day 2 & 8 tests. If you want to reduce your quarantine/self-isolation time you must also book a Test to Release.
Reduce your self isolation period from 10 days to 5
Results the next day.
Important: This is not part of the 2nd and 8th day testing.
For quick, affordable and accurate detection of the COVID-19 virus.
Results within 15 minutes
For Fit to Fly certificates or general work place testing for detection of COVID-19
Results by: The next day, within 2 days or by 5am the next day
For thorough detection of COVID-19 and required for travel to some countries.
It is your responsibility to make sure that the country you are travelling to accepts this test result.
Results within 24 hours
WEP Clinical is a healthcare services provider that helps connect patients around the world with much-needed treatments. We do this by working with companies to set up and manage Expanded Access Programmes (EAPs) and Post-Approval Named Patient Programs (PA-NPPs).
EAPs allow Sponsors to supply investigational (Pre-Approval) drugs, that are still in clinical trials, to patients who cannot enroll into active studies. NPPs allow sponsors to supply commercialized (Post-Approval) drugs to patients living in countries where they are not yet approved and available.
As the Market Leader in providing early access to innovative new drugs, we offer bespoke, end-to-end solutions that can include data collection and safety management. Our versatile service offering can be adapted to suit your company’s needs at any stage in the drug development, review, or commercialization process.
To further support Sponsors and CROs, we provide nursing services for companies running decentralized clinical trials. We also have clinical trial sourcing capabilities for customers looking to supply their active studies and drug development programs. Find out more about our services below.
Helping Sponsors provide investigational drugs to patients outside the clinical trial setting, to fulfil unmet clinical needs
Helping Sponsors provide approved drugs to patients living in countries where they are not registered or commercially available
Taking a Sponsor’s FDA-approved product through the approval, reimbursement, and market launch processes in Europe
Ensuring products are stored, handled, and distributed compliantly, with continuous monitoring and allowing complete Sponsor oversight
Using our extensive knowledge of the regulatory process in over 100 countries to get Sponsor products expeditiously to where they are needed most
Providing Data Collection solutions during your EAP or NPP program, which could be used to support clinical trial submissions
Delivering effective Safety Management solutions to support regulatory requirements during EAPs and NPPs
Sourcing pharmaceuticals, ancillary clinical supplies and active pharmaceutical ingredients for clinical trial and drug development programs
WEP Clinical possess all the necessary licenses to allow us to source, handle, store and distribute pharmaceutical drugs and controlled substances in the US, EU and ROW. All of our activities are conducted under the strict guidelines of GCP, GDP and GMP, and we have a robust set of SOPs that guide all company processes and procedures. We would be happy to provide further detail on this as requested.
WEP offers first-in-class nursing solutions for Sponsors and CROs running Decentralized Clinical Trials across the US and Europe.
We bring the clinical trial to the patient by conducting study procedures, administering treatments, monitoring patient outcomes, and managing the delivery of specimens to a designated laboratory, all from within the patient home.
Our team of research nurses are ICH-GCP certified and have extensive clinical experience caring for diverse patient groups across multiple therapy areas, including Oncology, Haematology, Rare Diseases, Neurological Diseases and Rheumatology. WEP nurses engage in ongoing research and competency training and are supported by a Clinical Trial Nurse Management team.
A pharmaceutical company developing a new treatment for a rare neurodegenerative disease had to set very strict eligibility criteria for its clinical trials. […]
A leading pharmaceutical company wanted to distribute its approved product for the treatment of a rare congenital disease into new markets where it has not yet received regulatory approval. […]
A pharmaceutical company based in North America received EMA marketing approval for its bioequivalent product for an ultra-rare disease. […]
